R. Jordan (Birmingham (West Midlands), United Kingdom), E. Brakema (Amsterdam, Netherlands), P. Honkoop (Leiden, Netherlands), P. White (London, United Kingdom)
Using a rapid prioritisation process to identify health research priorities in LMICs
A. Dickens (Birmingham, United Kingdom), P. Adab (Birmingham, United Kingdom), K. Cheng (Birmingham, United Kingdom), C. Chi (Beijing, China), B. Cooper (Birmingham, United Kingdom), J. Correia De Sousa (Glasgow, United Kingdom), A. Enocson (Birmingham, United Kingdom), A. Farley (Birmingham, United Kingdom), N. Gale (Birmingham, United Kingdom), K. Jolly (Birmingham, United Kingdom), S. Jowett (Birmingham, United Kingdom), M. Maglakelidze (Tbilisi, Georgia), T. Maglakelidze (Tbilisi, Georgia), S. Martins (Sao Paulo, Brazil), R. Ristovska (Skopje, FYROM (Macedonia)), A. Sitch (Birmingham, United Kingdom), K. Stavrikj (Skopje, FYROM (Macedonia)), R. Stelmach (Sao Paulo, Brazil), A. Turner (Birmingham, United Kingdom), S. Williams (Glasgow, United Kingdom), R. Jordan (Birmingham, United Kingdom)
|  |
Peak-flow or portable spirometry as a replacement for Spirometry in the diagnosis of COPD and Asthma
S. Nair (Trivandrum, India), A. Padmanabhan (Trivandrum, India), A. Kumari (Trivandrum, India)
| |
Describing “real world” COPD patients in primary care in Germany – Findings of the BeoNet-Registry
H. Lingner (Hanover, Germany), C. Klett-Tammen (Hanover, Germany), A. Kuhlmann (Hanover, Germany), T. Schmidt (Hanover, Germany), J. Lutter (Hanover, Germany), J. Von Der Schulenburg (Hanover, Germany), M. Kreuter (Hanover, Germany), T. Welte (Hanover, Germany)
|  |
Health status changes in Dutch regular care COPD patients classified per GOLD category
H. Alma (Groningen, Netherlands), C. De Jong (Groningen, Netherlands), R. Sanderman (Groningen, Netherlands), J. Kocks (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands)
| |
Asthma and Chronic Obstructive Pulmonary disEase Decision Support System (Asthmacope DSS) for managing neglected chronic respiratory diseases in resource constrained primary health care setting in India
R. Anchala (Pune, India), M. Shevade (Pune, India)
| |
Health seeking behaviour and care provided to obstructive airway disease patients in Trivandrum, South India
P. Arjun (Trivandrum, India), S. Nair (Trivandrum, India), A. Kumari (Trivandrum, India)
| |
COPD GOLD 2017 guidelines adherence in Swiss pulmologists and general practitioners
J. Marmy (Liestal, Basel, Switzerland), J. Diedrich (Basel, Switzerland), T. Dieterle (Liestal, Basel, Switzerland), J. Leuppi (Liestal, Basel, Switzerland)
| |
Improvement of self-reported physical functioning with tiotropium/olodaterol in Central and Eastern European COPD patients
A. Valipour (Wien, Austria), M. Tamm (Basel, Switzerland), J. Kociánová (Ostrava-Poruba, Czech Republic), V. Bayer Zubek (Biberach an der Riss, Germany), A. Medvedchikov (Vienna, Austria), M. Haaksma Herczegh (Vienna, Austria), J. Mucsi (Gödöllo, Hungary), Z. Fridlender (Jerusalem, Israel), C. Toma (Bucharest, Romania), A. Belevsky (Moscow, Russian Federation), B. Matula (Nitra, Slovakia), J. Šorli (Topolšica, Slovenia)
| |
National and international expansion of capacity building model of India for primary care physicians(PCPs) in the management of COPD & Asthma
H. Chandwani (Gurgaon, India), S. Sinha (Gurgaon, India), S. Jain (Gurgaon, India), P. Gupta (Gurgaon, India), S. Bhalla (Gurgaon, India), B. Mohan (Bengaluru, India), M. Barne (Pune, India), S. Salvi (Pune, India), D. Prabhakaran (Gurgaon, India)
| |
The impact of obstructive airway diseases (OADs) training on knowledge level of 385 allied health professionals in India
M. Shevade (Pune, India), K. Apte (Pune, India), S. Madas (Pune, India), N. Kale (Pune, India), S. Salvi (Pune, India)
| |
The MISTRAL study: COPD treatment by general practitioners – diagnosis, treatment decisions, and cooperation with pneumologists
T. Voshaar (Moers, Germany), K. Karmand (Moers, Germany), L. Krott (Berlin, Germany)
| |
Step-down of non-indicated triple therapy in COPD using routine primary care data: A regional pilot study
A. Creamer (Bristol, United Kingdom), E. Mallett (Bristol, United Kingdom), A. Stinchcombe (Bristol, United Kingdom), J. Calvert (Bristol, United Kingdom)
| |
Why prescribe ICS to Dutch COPD patients in primary care, and when and how to stop. Data from focus groups with patients and health care providers
C. De Jong (Groningen, Netherlands), J. Van Boven (Groningen, Netherlands), T. Schermer (Nijmegen, Netherlands), R. Riemersma (Groningen, Netherlands), E. Brill (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), T. Van Der Molen (Groningen, Netherlands), J. Kocks (Groningen, Netherlands)
| |
Data mining Inhaled corticosteroid Beclometasone dipropionate (bdp) equivalent dose from routine primary care records
C. Newby (London, United Kingdom), D. Marke (LondonLondon, United Kingdom), S. Mckibben (LLonodnondonLondon, United Kingdom), C. Griffiths (LondonLLonodnondonLondon, United Kingdom)
| |
REducing Delay through edUcation on eXacerbations (REDUX) in patients with COPD
C. Hallensleben (Leiden, Netherlands), J. Biewenga (Leiden, Netherlands), J. van Boven (Groningen, Netherlands), N. Chavannes (Leiden, Netherlands)
| |
The risk of repeated hospitalizations for exacerbations of chronic obstructive pulmonary disease
R. Khamitov (Kazan, Russian Federation), A. Iakupova (Kazan, Russian Federation), A. Zinnatullina (Kazan, Russian Federation)
| |
Prediction of future COPD exacerbations - DOSE index or a history of exacerbations?
B. Stallberg (Uppsala, Sweden), M. Högman (Uppsala, Sweden), C. Janson (Uppsala, Sweden), K. Bröms (Gävle, Sweden), A. Malinovschi (Uppsala, Sweden), K. Lisspers (Uppsala, Sweden)
| |
Understanding referral to Pulmonary Rehabilitation for COPD patients by Primary Health Care staff - a qualitative study using the Theoretical Domains Framework.
J. Watson (Birmingham, United Kingdom), R. Jordan (Birmingham, United Kingdom), P. Adeb (Birmingham, United Kingdom), A. Enocson (Birmingham, United Kingdom), S. Greenfield (Birmingham, United Kingdom), I. Vlaev (Warwick, United Kingdom)
| |
TANDEM (Tailored intervention for ANxiety and DEpression Management in COPD) trial: Qualitative interviews with health care professionals from the pilot phase
c. dibao-dina (Tours, France), S. Taylor (London, United Kingdom), H. Pinnock (Edinburgh, United Kingdom), E. Steed (London, United Kingdom), S. Saqi-Waseem (London, United Kingdom), M. Kelly (London, United Kingdom)
| |
Participant experiences in TANDEM feasibility pilot
A. Barradell (Leicester, United Kingdom), R. Sohanpal (London, United Kingdom), K. Mammoliti (London, United Kingdom), A. Moore (London, United Kingdom), H. Pinnock (Edinburgh, United Kingdom), S. Taylor (London, United Kingdom)
| |